title: Low-molecular-weight heparin use in special populations.
abstract: Because many obese patients and patients with underlying renal dysfunction require surgical intervention, it is important to examine the dosage recommendations and monitoring required with low-molecular-weight heparins.
authors.affiliation: University of Kentucky Chandler Medical Center, Lexington 40536-0293, USA.
authors.forename: Peter N
authors.initials: PN
authors.lastname: Johnson
authors.forename: Kelly M
authors.initials: KM
authors.lastname: Smith
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use; D015897:Comorbidity; D003401:Creatine / Q000652:urine; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000453:epidemiology*; D008991:Monitoring, Physiologic; D009765:Obesity / Q000453:epidemiology*; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D013923:Thromboembolism / Q000453:epidemiology* / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D003401:Creatine